Darifenacin

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 69097-431
  • Package NDC 69097-431-02
  • Package NDC 69097-431-05
  • Package NDC 69097-431-15
  • Application number ANDA207664
  • SPL ID 99ca2704-b757-4f10-be5c-bd01dff69b10
  • SPL set ID 6e8470d1-c3e6-4644-b70a-aa47ddf79676
  • UNII CR02EYQ8GV
  • RxCUI 485421
  • RxCUI 485423

What the source publishes

Labeler
Cipla USA Inc.
Active ingredients
Darifenacin Hydrobromide
Form
TABLET, EXTENDED RELEASE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:69097-431_99ca2704-b757-4f10-be5c-bd01dff69b10
{
  "name": "Darifenacin",
  "splId": "99ca2704-b757-4f10-be5c-bd01dff69b10",
  "labels": [
    {
      "setId": "6e8470d1-c3e6-4644-b70a-aa47ddf79676",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6e8470d1-c3e6-4644-b70a-aa47ddf79676",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6e8470d1-c3e6-4644-b70a-aa47ddf79676"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Cipla USA Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-431-02)",
      "package_ndc": "69097-431-02",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20160901"
    },
    {
      "sample": false,
      "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-431-05)",
      "package_ndc": "69097-431-05",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20160901"
    },
    {
      "sample": false,
      "description": "1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-431-15)",
      "package_ndc": "69097-431-15",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20160901"
    }
  ],
  "productId": "69097-431_99ca2704-b757-4f10-be5c-bd01dff69b10",
  "useDomain": "unknown",
  "dosageForm": "TABLET, EXTENDED RELEASE",
  "productNdc": "69097-431",
  "deaSchedule": null,
  "genericName": "Darifenacin Hydrobromide",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "DARIFENACIN HYDROBROMIDE",
      "strength": "7.5 mg/1"
    }
  ],
  "applicationNumber": "ANDA207664",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20160901",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "unii": [
      "CR02EYQ8GV"
    ],
    "rxcui": [
      "485421",
      "485423"
    ],
    "spl_set_id": [
      "6e8470d1-c3e6-4644-b70a-aa47ddf79676"
    ],
    "manufacturer_name": [
      "Cipla USA Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20261231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:69097-431_99ca2704-b757-4f10-be5c-bd01dff69b10"